Monitoring Of Wilms' Tumor 1 (Wt1) Expression In Peripheral Blood (Pb) Of Patients With Myelodysplastic Syndromes (Mds) By A Standardized European Leukemia Net (Eln)-Certified Assay To Detect Minimal Residual Disease (Mrd) And Guide Therapeutic Interventions Following Allogeneic Transplantation
BLOOD（2014）
摘要
Background:
更多查看译文
关键词
myelodysplastic syndromes,standardized european leukemia net,minimal residual disease,wilms,tumor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要